Relative Bioavailability of LY03010 Compared to Listed Drug

NCT04922593 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Psychotic Disorders
Mood Disorders
Schizophrenia Spectrum
Mental Disorders
Antipsychotic Agents
Tranquilizing Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Psychotropic Drugs
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action

Interventions

DRUG: LY03010; paliperidone palmitate
DRUG: INVEGA SUSTENNA

Sponsor

Luye Pharma Group Ltd.